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Plasma  Concentrations  of  Morphine 
during  Postoperative  Pain  Control
Department of Anesthesiology and Pain Medicine, School of Medicine, Ewha Womans University, Seoul, Korea
Hah c k  S o o Pa r k ,  MD,  J on g  Ha k  Ki m,  MD,  Y i  J e on g  Ki m,  MD,  a nd  Dong  Yeon  Kim,  MD
Background: 
Morphine has been commonly used for postoperative pain control. We measured plasma concentrations of 
morphine and compared the efficacy and safety of continuous epidural analgesia (CEA) using morphine- 
bupivacaine with intravenous patient controlled analgesia (IV-PCA) with morphine for 48 hrs after the end 
of the operation.
Methods: 
Nineteen patients undergoing Mile's operation were assigned to receive a morphine loading dose of 5 mg 
followed by IV-PCA with 0.1% morphine (IV-PCA group, n = 9) or a morphine loading dose of 2 mg and 0.125% 
bupivacaine 10 ml, followed by CEA with 0.004% morphine and 0.075% bupivacaine at a rate of 5 ml/hr (CEA 
group, n = 10). The plasma concentrations of morphine were measured and visual analog scales (VAS) for 
p a i n  w e r e  r e c o r d e d  a t  1 ,  6 ,  1 2 ,  2 4 ,  a n d  4 8  h r  p o s t o p e r a t iv e l y  a n d  t h e  e f f e c t s  o n  r e s p i r a t i o n  a n d  a n y  o t h e r 
side effects were noted.
Results: 
The mean maximal and minimal levels of plasma morphine were 40.2 ± 21.2 ng/ml and 23.4 ± 9.7 ng/ml 
for the IV-PCA group and 11.8 ± 3.5 ng/ml and 8.2 ± 1.9 ng/ml for the CEA group, respectively. Resting and 
dynamic pain scores were significantly lower in the CEA group than in the IV-PCA group. There were no 
significant differences for the effects on respiration and for any side effects between the two groups.
Conclusions: 
We evaluated plasma concentrations of morphine with CEA using morphine-bupivacaine and IV-PCA using 
morphine for the postoperative pain control. The CEA group had better postoperative analgesia than that of 
the IV-PCA group and the incidence of side effects were not significantly different between the two groups.  
(Korean  J  Pain  2011;  24:  146-153)
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INTRODUCTION
　　Until recently, it was a common practice for physician 
to administer opioids intermittently to patients with intra-
muscular (IM) injections for postoperative pain control. IM 
injections, however, often led to insufficient analgesia, and 
hence, other approaches have been used recently to pro-
vide better postoperative pain relief. Now some of the most 
commonly used methods are (a) continuous epidural an-
algesia (CEA) in which a catheter is placed into the epidural 
space, constantly administering opioids combined with lo-
cal anesthetics; and (b) intravenous patient-controlled an-
algesia (IV-PC A), w hich uses a PC A pum p that deliv ers 
opioids or nonsteroidal anti-inflammatory drugs (NSAIDs) 
intravenously.
　　Morphine is a commonly used postoperative pain con-
t r o l  d r u g .  I n j e c t i n g  i t  i n t o  t h e  e p i d u r a l  s p a c e  o r  v e i n  
through a PCA device is effective for postoperative pain 
relief. Nonetheless, there have been reports about higher 
postoperative  pain  control  effects  rendered  by  epidural 
m o r p h i n e  i n j e c t i o n s  c o m p a r e d  w i t h  I M  i n j e c t i o n s  o r  
IV-PCA  [1].  Several  studies  have  reported  attempting 
postoperative  pain  control  through  epidural  injection  of 
morphine. The positive effects included pain control effi-
cacy such as a broader range of duration of action [2-6]. 
IV-PCA has been associated with fewer side effects and 
hence, greater safety and has a simple procedure, all of 
which contributes to its popularity and wide use [7,8].
　　Absorption of opioids and their analgesic effects can 
vary considerably from patient to patient. Since there are 
c o n c e r n s  o v e r  o p i o i d - r e l a t e d  a d v e r s e  e v e n t s ,  p h y s i c i a n s 
and patients tend to favor smaller doses when administer-
ing opioids. Graves et al. [9] used IV morphine injections 
for postoperative pain control. They measured the plasma 
c o n c e n t r a t i o n s  o f  m o r p h i n e  a n d  o b s e r v e d  i t s  a n a l g e s i c  
effects.  They  found  that  the  plasma  morphine  concen-
tration with minimal analgesia was 20-40 ng/ml, and that 
satisfactory pain control was achieved at a concentration 
level of 40 ng/ml or higher. Rawal et al. [10] injected 2 
mg of morphine epidurally and observed its effects, which 
included adequate analgesial (despite the drug’s low level 
of plasma concentrations) and an extended period of ac-
tion, i.e., 10 hours or longer. Regarding epidural admin-
istration  of  morphine,  some  studies  have  found  little 
co-relation between blood morphine concentration and the 
analgesic efficacy of morphine since they based their find-
ings on the comparative data of the highest blood mor-
phine concentration achieved under either epidural admin-
istration or IV administration [11]. In this study, we enrolled 
patients who had been diagnosed with rectal cancer and 
were scheduled to undergo Miles’ operation at this hospital. 
We assigned them to either the IV-PCA group, receiving 
a  morphine-based  IV-PCA  treatment,  or  to  the  CEA 
group, receiving a mixture of morphine and bupivacaine 
delivered continuously through epidural catheter. In each 
group, we measured plasma concen trations of morphine 
and observed the effects of each method on the patients’ 
respiration, analgesic control efficacy, and association with 
adverse events.
MATERIALS  AND  METHODS
　　The participating patients were scheduled to receive 
Miles’ operation at this hospital for rectal cancer; they ex-
pressed their interest in receiving postoperative pain relief. 
All patients were qualified for ASA physical status Class 
I or II. Exclusion criteria were those who were at advanced 
ages (i.e., 70 years or older), who had a psychiatric dis-
order, or who had shown dependency on or extra sensi-
tivity to the drugs used in the study. Approval was ob-
t a i n e d  f r o m  t h e  i n s t i t u t i o n a l  r e v i e w  b o a r d  ( I R B )  a t  t h i s 
hospital. On the day before the surgery, we visited with 
the patien ts and exp l ained to th em h o w the t w o pos t-
operative pain control methods (i.e., CEA and IV-PCA) are 
implemented. We informed them about the effects as well 
as possible adverse events of each method. We then let 
them choose a method and obtained their signed consent.
　　For pretreatment, all patients were given atropine sul-
fate (0.5 mg) in IM injection 1 hour prior to their surgery. 
With the CEA group, in the operating room before the sur-
gery began, we used the loss of resistance technique to 
identify the epidural space while inserting the needle in the 
intervertebral space between L2 and L3. After identifying 
the epidural space, we inserted an epidural catheter into 
the epidural space, making sure the catheter did not come 
in contact with blood or cerebrospinal fluid (CSF). For test-
ing, 0.375% bupivacaine (3 ml) combined with 0.0005% 
epinephrine was given through the epidural catheter. This 
test confirmed the positioning of the catheter inside the 
epidural space. For anesthesia, we injected the patients 
intravenously with thiopental sodium (5 mg/kg) and succi-
nylcholine  chloride  (1.5  mg/kg)  before  conducting  endo-148 Korean J Pain Vol. 24, No. 3, 2011
Table 1. Demographic Data
IV-PCA (n = 9) CEA (n = 10)
Age (yr)
Weight (kg)
Height (cm)
Sex (M/F , No.)
Duration of surgery (min)
Duration of Anesthesia (min)
44.4 ± 4.6
56.3 ± 14.1
164.2 ± 10.5
6/3
246.1 ± 66.0
288.9 ± 60.7
42.6 ± 3.6
51.4 ± 10.1
160.7 ± 6.6
5/5
254.0 ± 44.0
288.5 ± 49.0
Values are mean ± SD. There were no significant differences be-
tween the teo groups.
bronchial intubation. The intubation was followed by typical 
general anesthesia using midazolam (5 mg), fentanyl (200 
μg), N2O, and isoflurane. In addition, vecuronium was ad-
ministered for continued muscle relaxation.
　　When the surgery was concluded, extubation took place. 
Patients  were  transferred  to  their  recovery  room.  Upon 
their arrival in the recovery room, IV-PCA group received 
morphine (5 mg) intravenously; their IV line was hooked 
up to the PCA device (Walkmed, Medex, USA) which deliv-
ered a mixture of 0.1% morphine (100 ml) and ondansetron 
(4 mg). The bolus dose was 1 ml; the lockout time was 8 
minutes. During the first hour into the morphine admin-
i s t r a t i o n ,  p a t i e n t s  w e r e  a l l o w e d  t o  r e c e i v e  m e d i c a t i o n  
whenever they felt pain but only for a maximum of 5 times 
by  pressing  the  button;  from  the  second  hour  on,  the 
number was lowered to 4 times per hour. In the meantime, 
patients in the CEA group received 0.125% bupivacaine (10 
ml) combined with morphine (a 2 mg loading dose) immedi-
ately after they arrived in their recovery room. They then 
constantly received 0.075% bupivacaine solution containing 
0.004% morphine through the PCA device at a rate of 5 
ml/hr.
　　At 1, 6, 12, 24, and 48 hours after the surgery, a pain 
physician  visited  with  the  patients  and  collected  blood 
samples for plasma morphine concentration measurements 
and did an arterial blood gas analysis. The physician moni-
tored the patients’ respiratory rate and checked the se-
verity of pain. F or pain monitoring, the visual analogue 
scale (V AS) was used while specifying the pain scores as 
either resting pain scores (i.e., lying down) or dynamic pain 
scores (i.e., coughing forcefully). In addition, inquiries were 
made on the incidence of adverse events such as nausea, 
vomiting, pruritis, sedation, hypotension, and respiratory 
depression (i.e., per-minute breathing rate of 8 or less), 
as well as on morphine consumption in the IV-PCA group. 
In case of nausea and vomiting, 10 mg of metoclopramide 
was given if requested by the patient. Blood samples col-
lected at each of the above-mentioned postoperative hours 
for the analysis of the plasma morphine concentrations 
were deposited inside blood sample vials, free of anticoa-
gulants. Within 30 minutes after the blood was collected, 
t h e  sa m p l es  w e r e  su b j ec t ed  t o c e n t r if u ga t i o n a t  4
oC  to 
separate  the  serum.  Immediately  after  this,  the  se-
rum-free plasma was frozen at -70
oC and kept in cry-
opreservation  until  the  plasma  morphine  concentrations 
were measured by means of radioimmunoassay.
　　All  results  were  expressed  as  mean  ±  standard 
deviation. Statistical analyses were d one with SPSS ver. 
12.0 software (SPSS Inc., USA). For inter-group compar-
ison, the non-parametric Mann-Whitney U test was used. 
Incidences of adverse events were analyzed with Fisher's 
exact test; the results were considered statistically sig-
nificant if the P value was less than 0.05.
RESULTS
　　N o  s i g n i f i c a n t  d i f f e r e n c e s  w e r e  f o u n d  b e t w e e n  t h e  
IV-PCA and CEA groups in terms of age, weight, duration 
of surgery, and duration of anesthesia (Table 1). The mean 
total  morphine  consumption  during  the  48-hour  post-
operative period was 66.1 ± 14.0 mg and 11.6 mg in the 
I V - P C A  a n d  C E A  g r o u p s ,  r e s p e c t i v e l y .  I n  t h e  I V - P C A  
group, the mean maximal and minimal values for the plas-
ma morphine concentration were 40.2 ± 21.2 ng/ml and 
23.4 ± 9.7 ng/ml, respectively. The corresponding values 
in the CEA group were 11.8 ± 3.5 ng/ml and 8.2 ± 1.9 
ng/ml, respectively (T able 2).
　　There were no significant differences in the data upon 
inter-group comparison for the respiratory rate and arte-
rial blood gas analysis, which were collected to examine 
the effects of the drugs used in this study on respiration 
(Table 3). In terms of the VAS pain scores, the CEA group 
scored significantly lower than that of the IV-PCA group, 
f o r  b o t h  r e s t i n g  p a i n  s c o r e s  a n d  d y n a m i c  p a i n  s c o r e s  
measured at 1, 6, 12, 24, and 48 hours after the surgery 
(P ＜ 0.05) (T able 4).
　　Side effects experienced by the patients included nau-
sea, vomiting, pruritis, and sedation. No severe adverse 
events were reported. In each of the above mentioned side 
e f f e c t s ,  n o  s i g n i f i c a n t  i n t e r - g r o u p  d i f f e r e n c e  w a s  f o u n d 
(Table 5).HS Park, et al / Plasma Morphine during Postoperative Pain Control 149
Table 2. Total Accumulated Dose and Plasma Morphine Levels
IV-PCA (n = 9)
Patient
number
Total accumulated dose (mg) Plasma morphine levels (ng/ml)
PO 1 hr 6 hr 12 hr 24 hr 48 hr PO 1 hr 6 hr 12 hr 24 hr 48 hr
1
2
3
4
5
6
7
8
9
Mean
(SD)
3.0
5.5
1.5
1.4
2.5
1.5
3.7
3.5
4.5
3.0
1.4
23.8
26.0
16.5
 9.2
14.1
17.5
21.9
13.4
12.9
17.3
 5.6
42.3
31.0
22.6
21.6
17.4
21.0
27.5
15.5
14.7
23.7
 8.8
60.0
45.0
47.7
54.2
39.1
40.5
32.7
28.4
56.7
44.9
10.8
69.9
51.4
73.6
88.0
54.8
77.8
52.2
50.5
76.5
66.1
14.0
40.0
59.3
22.5
27.9
17.9
27.7
40.8
86.0
40.0
40.2
21.2
21.8
52.8
29.8
40.0
34.2
38.2
52.6
15.8
47.1
36.9
13.0
15.6
24.7
23.9
40.0
20.6
33.6
24.7
18.1
10.9
23.6
 8.9
 6.9
18.9
26.7
49.6
52.9
13.1
30.3
18.7
27.5
27.2
15.5
 3.1
20.4
23.3
38.1
20.4
24.5
32.1
27.7
20.6
23.4
 9.7
CEA (n = 10)
Patient
number
Total accumulated dose (mg) Plasma morphine levels (ng/ml)
PO 1 hr 6 hr 12 hr 24 hr 48 hr PO 1 hr 6 hr 12 hr 2 4hr 48 hr
1
2
3
4
5
6
7
8
9
10
Mean
(SD)
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
2.2
0
3.2
3.2
3.2
3.2
3.2
3.2
3.2
3.2
3.2
3.2
3.2
0
4.4
4.4
4.4
4.4
4.4
4.4
4.4
4.4
4.4
4.4
4.4
0
6.8
6.8
6.8
6.8
6.8
6.8
6.8
6.8
6.8
6.8
6.8
0
11.6
11.6
11.6
11.6
11.6
11.6
11.6
11.6
11.6
11.6
11.6
 0
10.9
10.8
11.2
18.6
 7.5
10.9
10.3
 9.1
11.5
17.5
11.8
 3.5
10
 6.9
 4.3
12.8
 6.4
 5.1
 9.9
10.1
 8.8
16.1
 9.0
 3.6
 8.1
 9.4
 5.6
 7.8
 3.9
 2.1
11.3
10.5
 7.8
10.6
 7.7
 3.0
 5.9
 9.1
 5.2
 5.2
 6.8
12.3
13.1
11
 8.9
10.5
 8.8
 2.9
 7.3
 7.6
 6.8
 5.1
 7.1
10
10.8
8
 7.9
11.2
 8.2
 1.9
PO: postoperative.
DISCUSSION
　　R e c e n t l y ,  b o t h  e p i d u r a l  a n d  I V  a d m i n i s t r a t i o n s  o f  
opioids have been widely used in postoperative pain relief. 
An example of epidural administration is CEA, and opioids 
reduce  the  occurrence  of  dose-related  adverse  events 
when used in combination with local anesthetics and pro-
duce synergistic effects for pain control. In the study by 
de Leon-Casasola et al. [12], 4,227 cancer patients re-
ceiv ed 0.05-0.1% bupivacaine and 0.01% morphine with 
epidural injections at a rate of 5-10 ml/hr postoperatively. 
The results demonstrated the pain control efficacy of the 
bupivacaine-morphine  regimen.  Other  researchers  have 
reported on epidural administration of morphine (2 mg) in 
patients with pain. The maximal pain-relieving effect was 
observed at 10-15 minutes after the administration; the 
action of morphine lasted 6-24 hours [13]. In this study, 
where a mixture of 0.004% morphine and 0.075% bupiva-
caine was delivered into the epidural space, we, too, ob-
served positive effects from the infusion throughout the 
study period since the patients invariably rated their pain 
as ‘3’ or lower on the VAS. Notwithstanding the reported 
frequency  and  popularity  of  epidural  administration  of 
morphine as an excellent pain control method, the possi-
bilities of adverse events, such as late respiratory depres-
sion, still exist due to the poor lipid solubility of morphine 150 Korean J Pain Vol. 24, No. 3, 2011
Table 5. The Incidence of Side Effects
IV-PCA (n = 9) CEA (n = 10)
Nausea & Vomiting
Pruritis
Sedation
Respiratory depression
4 (44)
2 (22)
3 (33)
0 (0)
5 (50)
4 (40)
2 (20)
0 (0)
Values represent number of patients. Values in parentheses are 
percentages. There were no significant differences between the 
two groups.
Table 4. The Pain Scores (VAS)
IV-PCA (n = 9) 
PO 1 hr 6 hr 12 hr 24 hr 48 hr
 RPS
 DPS
4.6 ± 1.7
6.6 ± 1.4
2.7 ± 1.1
5.6 ± 1.4
2.2 ± 1.6
4.2 ± 2.0
2.4 ± 1.6
5.6 ± 1.7
2.8 ± 1.4
5.6 ± 1.2
CEA (n = 10)
 RPS
 DPS
0.6 ± 1.0*
1.6 ± 1.5*
0.4 ± 0.5*
2.2 ± 1.3*
0.3 ± 0.7*
1.9 ± 1.4*
0.3 ± 0.7*
2.3 ± 1.3*
0.6 ± 1.1* 
2.2 ± 0.9*
Values are mean ± SD. PO: postoperative, RPS: rest pain score, DPS: dynamic pain score. *P ＜ 0.05 compared with Group IV-PCA. 
Table 3. Arterial Blood Gases and Respiratory Rates (RR)
IV-PCA (n = 9) 
PO 1 hr 6 hr 12 hr 24 hr 48 hr
　PaO2 (mmHg)
　PaO2 (mmHg)
　RR (No/min)
156.7 ± 49.6
42.4 ± 3.8
17.6 ± 3.5
115.8 ± 26.8
40.8 ± 3.3
13.3 ± 2.9
104.8 ± 30.2
41.5 ± 4.5
15.9 ± 2.8
88.3 ± 18.0
43.7 ± 4.3
16.9 ± 3.0
76.9 ± 11.0
44.4 ± 4.6
15.8 ± 4.2
CEA (n = 10)
　PaO2 (mmHg)
　PaO2 (mmHg)
　RR (No/min)
158.4 ± 48.6
40.9 ± 5.4
15.9 ± 1.9
114.1 ± 47.3
39.7 ± 7.1
16.7 ± 2.2
109.2 ± 37.3
41.0 ± 6.3
17.8 ± 3.3
78.7 ± 15.4 
41.4 ± 4.1
16.9 ± 1.2
75.7 ± 9.9
42.6 ± 3.6
16.6 ± 1.5
Values are mean ± SD. PO: postoperative. There were no significant differences between the two groups.
[14]. The side effects of epidural opioid administration in-
clude nausea, vomiting, pruritis, urinary retention, seda-
tion, and respiratory depression. These effects are attrib-
utable  to  opioids  which,  once  injected  into  the  epidural 
space, enter into the CSF, travel in a cephalad direction, 
a n d  b e c o m e  a c t i v e  w i t h i n  t h e  b r a i n  [ 1 1 ] .  T h e  a f o r e -
mentioned respiratory depression is seen, though rarely, 
in elderly or high-risk patients, as well as with varying 
doses of opioids. Thus, physicians must take into consid-
eration the patient’s  age  and  overall  physical  condition, 
and the type of surgery when deciding upon an optimal 
dose of morphine.
　　IV-PCA is an effective way to control pain because 
it is easy to use and is associated with fewer side effects 
and higher patient satisfaction. When compared with IM 
injection  for  opioid  administration,  IV-PCA  has  greater 
analgesia, helps reduce the consumption of opioids, leads 
to less sedation and better nighttime sleep, facilitates early 
ambulation, results in fewer pulmonary complications, and 
ensures higher patient satisfaction [15]. In terms of the 
analgesia of IV-PCA alone, a previous study has reported 
satisfactory pain control results, indicated by VAS scores 
of ‘4’ or lower [14]. In that regard, dynamic pain scores 
in this study, which were ‘4’ or higher on the VAS, indicate 
that pain relief of the IV-PCA alone was not too effective. 
Similar to what we found, some studies have reported a 
relative weakness in analgesia for IV-PCA compared to 
epidural administration of opioids [14,16].
　　Depending on personal preference, patients may or 
may not feel comfortable about undergoing CEA, and may 
therefore choose IV-PCA as an alternative for themselves. HS Park, et al / Plasma Morphine during Postoperative Pain Control 151
A previous study showed high levels of patient satisfaction 
with both CEA and IV-PCA using morphine [16]. The de-
termining factors of the patients response included an-
algesia, incidence  of  adverse events,  less  invasive care, 
awareness of pain management importance, and treatment 
efficacy of the physician. The reported strengths of CEA 
were the ability for outstanding pain control and lucidity 
in patients. CEA was also favored by older patients, who 
generally  prefer  their  medication  administered  by  their 
physician rather than by themselves and whose probability 
of developing sedation is higher. The strength of IV-PCA, 
on the other hand, was that it could be operated easily. 
Postoperative pain is reportedly most intense during the 
first 24 hours into recovery. It lessens gradually over the 
next 24-hour period, and is nearly non-existent in 3 to 
4 days [17]. In this study, we continued to monitor for 
p a i n  u n t i l  4 8  h o u r s  ( o r  f o r  f u l l  2  d a y s )  f o l l o w i n g  t h e  
surgery.
　　Using morphine for pain control in various clinical sit-
uations requires knowledge about the metabolization of the 
drug,  a  thorough  understanding  of  its  pharmacological 
mechanisms, and the ability to predict possible adverse 
events. We reviewed several studies that measured plasma 
concentrations of morphine. Berkowitz et al. [18] reported 
that the mean half-life of morphine, injected either IV or 
IM, was 2 hours. They reported that sufficient analgesia 
involved fast absorption of the opioid into the systemic cir-
c u l a t i o n  ( e v e n  t h r o u g h  I M  i n j e c t i o n ) ,  a c h i e v i n g  m a x i m a l  
blood morphine levels within 10 to 20 minutes, and plasma 
morphine concentrations of 50 ng/ml or higher. In another 
study [9], the plasma morphine concentration with minimal 
efficacy was observed in postoperative patients who re-
ceived  morphine  through  IV-PCA.  The  concentration  in 
question was found to be 20-40 ng/ml; satisfactory pain 
con trol occurred at 40 ng/m l or higher; the respiratory 
rate, severity of pain, and sedation were all found to be 
related to the morphine plasma levels. In this study, we 
found that the mean maximal and minimal values of the 
morphine plasma level in the IV-PCA group were 40.2 ± 
2 1 . 2  n g / m l  a n d  2 3 . 4  ±  9 . 7  n g / m l ,  r e s p e c t i v e l y .  T h e s e 
numbers are consistent with previously reported morphine 
p l a s m a  l e v e l s  w i t h  m i n i m a l  e f f i c a c y ,  i . e . ,  2 0 - 4 0  n g / m l . 
Based on these data, we concluded that the patients’ rest-
ing pain scores were satisfactory while their dynamic pain 
scores (invariably ‘4’ or higher) were not so satisfactory.
　　Murakawa et al. [19] in their study on CEA evaluated 
morphine plasma levels for postoperative pain relief. They 
injected 3 mg of morphine into the epidural space immedi-
ately before concluding the surgery, and then continued to 
give morphine through CEA after the surgery. The post-
operative plasma concentrations of morphine were found 
to be 4.6 ng/ml. Its analgesic effects were at an appro-
priate le v el and remained as such throughout the study 
period without resulting in any severe complications, such 
as respiratory depression. This CEA morphine plasma level 
was low er than the morphine plasma le v el with minimal 
analgesia (i.e., 10-40 ng/ml) [18]. In this study, we found 
that the mean value of the CEA group’s plasma morphine 
concentrations ranged between 11.8 ± 3.5 ng/ml (maximal 
value) and 8.2 ± 1.9 ng/ml (minimal value). The CEA group 
i n v a r i a b l y  r a t e d  t h e i r  p a i n  a s  ‘3’  or  lower  on  the  VAS 
throughout the study period, possibly indicating pain con-
trol was adequate.
　　When injected into the epidural space, morphine pro-
duces its analgesic effect, as one study [13] suggests, by 
entering into the subarachnoid space and acting directly 
on specific opioid receptors in the substantia gelatinosa of 
the posterior horn cells of the spinal cord. Several other 
studies, too, have reported on opioids’ direct action on the 
spinal cord, and on their analgesic efficacy when injected 
into the epidural or subarachnoid space. Morphine, when 
administered  epidurally,  enters  into  the  systemic  circu-
lation and travels rapidly. Some previous studies reported 
that epid ur al injection of morp hine r esulted in a similar 
level of plasma morphine concentration when compared to 
IM injection of morphine [20,21]. In a study by Weddel and 
Ritter on morphine (5 mg/70 kg) that was injected epidur-
ally [22], the mean time to onset of significant effects was 
15 minutes; an adequate level of analgesia was found to 
last 37.9 hours. Based on what they found about the an-
algesic efficacy of morphine and its plasma concentration 
levels, researchers have supported the concept of the se-
lective action of morphine on the spinal cord. Rawal et al. 
[10] reported that morphine, in most patients, achieved its 
maximal plasma concentration (2.6-8.2 ng/ml) within 10 
minutes. The results, they argued, indicate morphine’s fast 
absorption into the blood stream. In addition, based on its 
e x t e n d e d  p e r i o d  o f  a c t i o n ,  e p i d u r a l l y  i n j e c t e d  m o r p h i n e  
might act on specific sites in the spinal cord. Kalman et 
al. [23] went further by measuring the level of morphine 
in the CSF. They found that the concentration of morphine 
(4 mg), injected epid urally, had increased rapidly in the 152 Korean J Pain Vol. 24, No. 3, 2011
CSF, with the mean maximal concentration achieved after 
10 to 30 minutes. However, morphine concentration levels 
varied considerably in the patients, and particularly so, in 
the CSF rather than in the plasma. They also found that 
CSF morphine concentrations at 30 minutes were not sig-
nifican tly related to V AS pain scores at 10 hours to 24 
hours.
　　M o r p h i n e ,  w h e n  d e l i v e r e d  b y  l u m b a r  e p i d u r a l  i n -
jections,  travels  in  the  cephalad  direction  and  arrives, 
mixed with the CSF, at the brain stem and fourth ventricle 
within 6 hours. Its blood concentration has not been found 
to be related to incidences of adverse events [20]. The 
CSF-morphine  mixture  slowly  travels  cephalad,  once  it 
reaches the fourth ventricle, it achieves equilibrium fast 
within 15 to 30 minutes [11]. When injected in a single, 
large-quantity dose, morphine reaches a high level of con-
centration inside the CSF; its concentration increases rap-
i d l y  a s  i t  t r a v e l s  t o  t h e  b r a i n  a n d  r e a c h e s  t h e  f o u r t h  
ventricle. In contrast, when injected in a small quantity or 
in a certain quantity over a period of time, morphine will 
show  little  change  in  concentration  level  in  the  fourth 
ventricle. In one study, morphine was administered at a 
consistent rate and produced more positive effects, includ-
i n g  t h e  a b s e n c e  o f  r e s p i r a t o r y  d e p r e s s i o n  [ 2 4 ] .  I n  t h i s 
study, we did not measure CSF concentrations of mor-
phine. Pharmacodynamic results that are observed in the 
CSF will play, we suspect, a more direct role in explaining 
the long duration of action for epidurally injected morphine 
and its association with adverse events.
　　In summary, we compared the efficacy of two mor-
phine-based postoperative pain control methods in rectal 
cancer  patients  who  underwent  Miles’  operation.  We 
measured  plasma  morphine  concentrations  in  IV-PCA 
(receiving  morphine  only)  and  CEA  (receiving  a  mor-
phine-bupivacaine mixture) groups over 48 hours into the 
recovery. In addition, we observed the effects of the pain 
relief regimens on the patients’ respiration, their pain con-
t r o l  e f f i c a c y  a n d  t h e i r  a s s o c i a t i o n  w i t h  a d v e r s e  e v e n t s .  
Regarding  respiration  and  adverse  events,  we  found  no 
significant  differences  between  the  groups.  As  for  pain 
control efficacy measured by means of VAS pain scores, 
the pain scores for the CEA group were lower indicating 
a more effective pain relief. W e recommend that further 
research be done on the concentrations of morphine used 
in postoperative pain control, and on its action mecha-
nisms and effects.
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